Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

3.6.4.13: RNA helicase

This is an abbreviated version!
For detailed information about RNA helicase, go to the full flat file.

Word Map on EC 3.6.4.13

Reaction

a nucleoside triphosphate
+
H2O
=
a nucleoside diphosphate
+
phosphate

Synonyms

1a NTPase/helicase, Aquarius, AtHELPS, ATP-dependent helicase, ATP-dependent RNA helicase, ATP-dependent RNA helicase DDX3X, ATP-dependent RNA helicase DDX5, ATP/dATP-dependent RNA helicase, ATPase, ATPase/helicase, ATPase/RNA helicase, AtRH3, AtRH7, bel, BmL3-helicase, BMV 1a protein, BRR2, Brr2 RNA helicase, Brr2p, Cbu_0670, ChlR1 helicase, cold-shock DEAD-box protein A, CrhR, CsdA, CshA, CTHT_0005780, CTHT_0009470, DBP2, DbpA, DDX17, DDX19, DDX19B, DDX21, DDX21 RNA helicase, DDX25, DDX27, DDX3, DDX3X, DDX3Y, DDX4, DDX5, DDX58, DeaD, DEAD box helicase, DEAD box RNA helicase, DEAD-box ATP-dependent RNA helicase CshA, DEAD-box helicase, DEAD-box protein DED1, DEAD-box RNA helicase, DEAD-box rRNA helicase, DEAH box protein 34, DEAH-box protein 2, DEAH-box RNA helicase, DEAH/RHA RNA helicase, DED1, DENV NS3H, DEx(H/D)RNA helicase, DExD/H box RNA helicase, DEXD/H-box RNA helicase, dexh helicase, DExH protein RNA helicase A, DExH/D-Box protein RNA helicase A, DExH/D-box RNA helicase, DHX34, DHX36, DHX8, DHX9, Dhx9/RNA helicase A, DNA/RNA-dependent ATPase, EhDEAD1, EhDEAD1 RNA helicase, eIF4A, eIF4A helicase, eIF4AIII, eukaryotic initiation factor eIF 4A, frequency-interacting RNA helicase, FRH, FRQ-interacting RNA helicase, gonadotropin-regulated testicular RNA helicase, GRTH, GRTH/DDX25, HCV NS3 helicase, HEL-1, helicase, helicase 1, helicase B, helicase/nucleoside triphosphatase, HRpA, IBP160, increased size exclusion limit2, intron-binding protein 160, ISE2, KOKV helicase, Lmo1722, mitochondrial DEAD-box RNA helicase, Mss116p, mtr4, Mtr4p, NA-helicase, non structural protein 3, non-structural 3, non-structural protein 3, non-structural protein 3 protein, nonstructural protein 3, NPH-II, NS3, NS3 ATPase/helicase, NS3 helicase, NS3 NTPase/helicase, NS3 protein, NTPase/helicase, nucleoside 5'-triphosphatase, nucleoside triphosphatase/helicase, nucleoside triphosphatase/RNA helicase and 5'-RNA triphosphatase, NWMN_1985, p54 RNA helicase, p68, p68 RNA helicase, P72, PH1280, pre-mRNA-splicing ATP-dependent RNA helicase 28, protein NS3, Prp28, Prp43, Prp5, RENT1, RH22, RHA, RhlB, RIG-I, Rm62, RNA DEAD-box helicase, RNA helicase, RNA helicase A, RNA helicase Aquarius, RNA helicase BELLE, RNA helicase CrhR, RNA helicase CsdA, RNA helicase CshA, RNA helicase DDX17, RNA helicase DDX27, RNA helicase DDX3, RNA helicase Ddx39, RNA helicase DDX3X, RNA helicase DDX5, RNA helicase DDX6, RNA helicase DeaD, RNA helicase DHX34, RNA helicase DHX8, RNA helicase DHX9, RNA helicase HEL-1, RNA helicase Hera, RNA helicase ISE2, RNA Helicase p68, RNA helicase RHAU, RNA helicase UPF1, RNA splicing effector, RNA-dependent ATPase, RNA-dependent NTPase/helicase, RNA-helicase, RTPase, SA1885, Ski2-like helicase, slr0083, SNRNP200, spliceosomal DEAH-box RNA helicase, spliceosomal RNA helicase, SpolvlgA, Supv3L1, TaRH1, TGBp1 NTPase/helicase domain, Tk-DeaD, Triticum aestivum RNA helicase, Upf1, UPF1_1, UPF1_2, Vasa, VRH1, YxiN, ZmRH3, ZmRH3A, ZmRH3B

ECTree

     3 Hydrolases
         3.6 Acting on acid anhydrides
             3.6.4 Acting on acid anhydrides to facilitate cellular and subcellular movement
                3.6.4.13 RNA helicase

Engineering

Engineering on EC 3.6.4.13 - RNA helicase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
A115C/D262C
-
site-directed mutagenesis, the mutant shows activity, structure and substrate specificity similar to the wild-type
A115C/E224C
-
site-directed mutagenesis, the mutant shows activity, structure and substrate specificity similar to the wild-type
A115C/S229C
-
site-directed mutagenesis, the mutant shows activity, structure and substrate specificity similar to the wild-type
S108C/E224C
-
site-directed mutagenesis, the mutant shows activity, structure and substrate specificity similar to the wild-type
S108C/S229C
-
site-directed mutagenesis, the mutant shows activity, structure and substrate specificity similar to the wild-type
D755A
-
site-directed mutagenesis, mutation in the conserved BMV 1a protein helicase motif, the mutant shows abolished RNA recruitment and RNA stabilization, and thus RNA replication function, but normal accumulation, localization, and 2apol recruitment, the mutant shows 90% reduced ATPase activity compared to the wild-type enzyme
F788A
-
site-directed mutagenesis, mutation in the conserved BMV 1a protein helicase motif, the mutant shows abolished RNA recruitment and RNA stabilization, and thus RNA replication function, but normal accumulation, localization, and 2apol recruitment, the mutant shows 30% reduced ATPase activity compared to the wild-type enzyme
G781S
-
site-directed mutagenesis, mutation in the conserved BMV 1a protein helicase motif, the mutant shows abolished RNA recruitment and RNA stabilization, and thus RNA replication function, but normal accumulation, localization, and 2apol recruitment, the mutant shows 75% reduced ATPase activity compared to the wild-type enzyme
H903A
-
site-directed mutagenesis, mutation in the conserved BMV 1a protein helicase motif, the mutant shows abolished RNA recruitment and RNA stabilization, and thus RNA replication function, but normal accumulation, localization, and 2apol recruitment, the mutant shows 45% reduced ATPase activity compared to the wild-type enzyme
K691A
-
site-directed mutagenesis, mutation in the conserved BMV 1a protein helicase motif, the mutant shows abolished RNA recruitment and RNA stabilization, and thus RNA replication function, but normal accumulation, localization, and 2apol recruitment, the mutant shows 80% reduced ATPase activity compared to the wild-type enzyme
Q785A
-
site-directed mutagenesis, mutation in the conserved BMV 1a protein helicase motif, the mutant shows abolished RNA recruitment and RNA stabilization, and thus RNA replication function, but normal accumulation, localization, and 2apol recruitment, the mutant shows 65% reduced ATPase activity compared to the wild-type enzyme
Q785E
-
site-directed mutagenesis, mutation in the conserved BMV 1a protein helicase motif, the mutant shows abolished RNA recruitment and RNA stabilization, and thus RNA replication function, but normal accumulation, localization, and 2apol recruitment, the mutant shows 75% reduced ATPase activity compared to the wild-type enzyme
R791A
-
site-directed mutagenesis, mutation in the conserved BMV 1a protein helicase motif, the mutant shows abolished RNA recruitment and RNA stabilization, and thus RNA replication function, but normal accumulation, localization, and 2apol recruitment, the mutant shows 10% increased ATPase activity compared to the wild-type enzyme
R815L
-
site-directed mutagenesis, mutation in the conserved BMV 1a protein helicase motif, the mutant shows abolished RNA recruitment and RNA stabilization, and thus RNA replication function, but normal accumulation, localization, and 2apol recruitment, the mutant shows 60% increased ATPase activity compared to the wild-type enzyme
R938A
-
site-directed mutagenesis, mutation in the conserved BMV 1a protein helicase motif, the mutant shows abolished RNA recruitment and RNA stabilization, and thus RNA replication function, but normal accumulation, localization, and 2apol recruitment, the mutant shows 45% reduced ATPase activity compared to the wild-type enzyme
S790A
-
site-directed mutagenesis, mutation in the conserved BMV 1a protein helicase motif, the mutant shows abolished RNA recruitment and RNA stabilization, and thus RNA replication function, but normal accumulation, localization, and 2apol recruitment, the mutant shows 60% reduced ATPase activity compared to the wild-type enzyme
S790W
-
site-directed mutagenesis, mutation in the conserved BMV 1a protein helicase motif, the mutant shows abolished RNA recruitment and RNA stabilization, and thus RNA replication function, but normal accumulation, localization, and 2apol recruitment, the mutant shows 70% reduced ATPase activity compared to the wild-type enzyme
T812A/Y813A
-
site-directed mutagenesis, mutation in the conserved BMV 1a protein helicase motif, the mutant shows abolished RNA recruitment and RNA stabilization, and thus RNA replication function, but normal accumulation, localization, and 2apol recruitment, the mutant shows unaltered ATPase activity compared to the wild-type enzyme
K232A
K199A/T200A
H51A
-
site-directed mutagenesis, the mutant has an inactivated protease domain showing enhanced RNA helicase compared to wild-type full-length enzyme
R184Q/K185N/R186G/K187N
-
construction of the N-terminally truncated mutant NS3DELTA180 containing a mutated RNA substrate biding motif, the mutant shows reduced RTPase activity
D310H
-
site-directed mutagenesis of the V motif, leads to altered enzyme activity, overview
D313H
-
site-directed mutagenesis of the V motif, leads to altered enzyme activity, overview
H320D
-
site-directed mutagenesis of the V motif, leads to altered enzyme activity, overview
Y383A
-
site-directed mutagenesis, the mutation causes the formation of a higher order molecular weight species in binding of RNaseE by RhlB
H293A
-
mutation results in a protein with a significantly higher level of ATPase in the absence of RNA. The mutant protein still unwinds RNA. In the presence of RNA, the H293A mutant hydrolyzes ATP slower than wild-type
M1708A
S1369R
S1369R/M1708A
S1369R/Y1702A
Y1702A
D279A
site-directed mutagenesis, the mutation affects ATP hydrolysis
DELTA53-105
-
a region within the N-terminus of RHAU, referred to as the RSM, interacts with human telomerase RNA
F192E
site-directed mutagenesis, the mutant shows slightly reduced activity compared with the wild-type enzyme. Upf1F192E definitely prefers to unwind a dsDNA than to translocate it, strand switching
K191S
site-directed mutagenesis, the mutation affects ATP binding
K235A
site-directed mutagenesis of a conserved Lys residue in RNA binding domain dsRBD2, the mutation does not prevent purified full-length RNA helicase A from binding and unwinding duplex RNA in vitro, but efficiently inhibits RNA helicase A-stimulated HIV-1 RNA metabolism including the accumulation of viral mRNA and tRNALys3 annealing to viral RNA
K236A
site-directed mutagenesis of a conserved Lys residue in RNA binding domain dsRBD2, the mutation does not prevent purified full-length RNA helicase A from binding and unwinding duplex RNA in vitro, but efficiently inhibits RNA helicase A-stimulated HIV-1 RNA metabolism including the accumulation of viral mRNA and tRNALys3 annealing to viral RNA
K236E
-
mutant exhibits relatively minor reduction in interaction with SNV PCE
K50R
site-directed mutagenesis, ATPase dead mutant, fails completely to unwind triplex substrates
K54A
site-directed mutagenesis of a conserved Lys residue in RNA binding domain dsRBD1, the mutation does not prevent purified full-length RNA helicase A from binding and unwinding duplex RNA in vitro, but efficiently inhibits RNA helicase A-stimulated HIV-1 RNA metabolism including the accumulation of viral mRNA and tRNALys3 annealing to viral RNA
K54A/K55A
-
mutant exhibits relatively minor reduction in interaction with SNV PCE
K54A/K55A/K236E
-
triple mutant shows a severe reduction in interaction with junD post-transcriptional control element (PCE) or SNV PCE compared with wild-type
K55A
site-directed mutagenesis of a conserved Lys residue in RNA binding domain dsRBD1, the mutation does not prevent purified full-length RNA helicase A from binding and unwinding duplex RNA in vitro, but efficiently inhibits RNA helicase A-stimulated HIV-1 RNA metabolism including the accumulation of viral mRNA and tRNALys3 annealing to viral RNA
K829A
site-directed mutagenesis, mutation of the invariant lysine residue from motif I involved in ATP binding and hydrolysis drastically reduced Aquarius's ability to bind ATP and ADP and to hydroxadlyze ATP, the mutant shows significantly reduced ATPase activity compared to wild-type enzyme
K897del
site-directed mutagenesis, the mutant fails in unwinding the DNA substrates
Y1196A
site-directed mutagenesis, mutation of a conserved aromatic residue located near the putative RNA-binding surface of the RecA2 inhibits Aquarius's RNA-unwinding activity without changing its RNA-binding and ATPase properties, a helicase-deficient mutant
Y593F
-
expression of the mutant enzyme in SW620 cells leads to Snail repression, E-cadherin upregulation and vimentin repression
G199A
mutation in WALKER A motif, PCR-based mutagenesis, ATPase and RNA helicase activity lost
G460A
mutation of residues of the arginine finger within the active sites of ATP hydrolysis, no effect on either ATPase or RNA-unwinding activities
G463A
mutation of residues of the arginine finger within the active sites of ATP hydrolysis, no effect on either ATPase or RNA-unwinding activities
K200A
mutation in WALKER A motif, PCR-based mutagenesis, ATPase and RNA helicase activity lost
K200D
PCR-based mutagenesis, ATPase and RNA helicase activity lost
K200E
PCR-based mutagenesis, ATPase and RNA helicase activity lost
K200H
PCR-based mutagenesis, ATPase and RNA helicase activity lost
K200N
PCR-based mutagenesis, ATPase and RNA helicase activity lost
K200Q
PCR-based mutagenesis, ATPase and RNA helicase activity lost
K200R
PCR-based mutagenesis, ATPase and RNA helicase activity lost
Q457A
mutation of residues of the arginine finger within the active sites of ATP hydrolysis, 80% reduction of ATPase activity, no RNA helicase activity
R458A
mutation of residues of the arginine finger within the active sites of ATP hydrolysis, 90% reduction of ATPase activity, no RNA helicase activity
R459A
mutation of residues of the arginine finger within the active sites of ATP hydrolysis, no effect on either ATPase or RNA-unwinding activities
R461A
mutation of residues of the arginine finger within the active sites of ATP hydrolysis, no ATPase activity, no RNA helicase activity
R464A
mutation of residues of the arginine finger within the active sites of ATP hydrolysis, no ATPase activity, no RNA helicase activity
T201A
mutation in WALKER A motif, PCR-based mutagenesis, ATPase and RNA helicase activity lost
V462A
mutation of residues of the arginine finger within the active sites of ATP hydrolysis, no effect on either ATPase or RNA-unwinding activities
R806H
site-directed mutagenesis, the mutation resides in a positively charged surface of the KOW domain, far removed from the helicase core, and disrupts circadian rhythms
V142G
site-directed mutagenesis, the substitution near the N-terminus alters protein complex of frequency (FRQ) and white-collar complex (WCC)binding to FRH, but produces an unusual short clock period
R806H
-
site-directed mutagenesis, the mutation resides in a positively charged surface of the KOW domain, far removed from the helicase core, and disrupts circadian rhythms
-
V142G
-
site-directed mutagenesis, the substitution near the N-terminus alters protein complex of frequency (FRQ) and white-collar complex (WCC)binding to FRH, but produces an unusual short clock period
-
R806H
-
site-directed mutagenesis, the mutation resides in a positively charged surface of the KOW domain, far removed from the helicase core, and disrupts circadian rhythms
-
V142G
-
site-directed mutagenesis, the substitution near the N-terminus alters protein complex of frequency (FRQ) and white-collar complex (WCC)binding to FRH, but produces an unusual short clock period
-
R806H
-
site-directed mutagenesis, the mutation resides in a positively charged surface of the KOW domain, far removed from the helicase core, and disrupts circadian rhythms
-
V142G
-
site-directed mutagenesis, the substitution near the N-terminus alters protein complex of frequency (FRQ) and white-collar complex (WCC)binding to FRH, but produces an unusual short clock period
-
R806H
-
site-directed mutagenesis, the mutation resides in a positively charged surface of the KOW domain, far removed from the helicase core, and disrupts circadian rhythms
-
V142G
-
site-directed mutagenesis, the substitution near the N-terminus alters protein complex of frequency (FRQ) and white-collar complex (WCC)binding to FRH, but produces an unusual short clock period
-
R806H
-
site-directed mutagenesis, the mutation resides in a positively charged surface of the KOW domain, far removed from the helicase core, and disrupts circadian rhythms
-
V142G
-
site-directed mutagenesis, the substitution near the N-terminus alters protein complex of frequency (FRQ) and white-collar complex (WCC)binding to FRH, but produces an unusual short clock period
-
R806H
-
interacts with the circadian oscillator component FREQUENCY (FRQ), but interaction between the FRQ–FRHR806H complex (FFC) and White Collar Complex is severely affected
E168A
site-directed mutagenesis, the mutation eliminates ATP hydrolysis and helicase activity, and the mutant is unable to restore PexsD-lacZ activity to levels observed with wild-type DeaD
E168Q
site-directed mutagenesis, the mutation eliminates ATP hydrolysis and helicase activity, and the mutant is unable to restore PexsD-lacZ activity to levels observed with wild-type DeaD
E168A
-
site-directed mutagenesis, the mutation eliminates ATP hydrolysis and helicase activity, and the mutant is unable to restore PexsD-lacZ activity to levels observed with wild-type DeaD
-
E168Q
-
site-directed mutagenesis, the mutation eliminates ATP hydrolysis and helicase activity, and the mutant is unable to restore PexsD-lacZ activity to levels observed with wild-type DeaD
-
E168A
-
site-directed mutagenesis, the mutation eliminates ATP hydrolysis and helicase activity, and the mutant is unable to restore PexsD-lacZ activity to levels observed with wild-type DeaD
-
E168Q
-
site-directed mutagenesis, the mutation eliminates ATP hydrolysis and helicase activity, and the mutant is unable to restore PexsD-lacZ activity to levels observed with wild-type DeaD
-
E168A
-
site-directed mutagenesis, the mutation eliminates ATP hydrolysis and helicase activity, and the mutant is unable to restore PexsD-lacZ activity to levels observed with wild-type DeaD
-
E168Q
-
site-directed mutagenesis, the mutation eliminates ATP hydrolysis and helicase activity, and the mutant is unable to restore PexsD-lacZ activity to levels observed with wild-type DeaD
-
E168A
-
site-directed mutagenesis, the mutation eliminates ATP hydrolysis and helicase activity, and the mutant is unable to restore PexsD-lacZ activity to levels observed with wild-type DeaD
-
E168Q
-
site-directed mutagenesis, the mutation eliminates ATP hydrolysis and helicase activity, and the mutant is unable to restore PexsD-lacZ activity to levels observed with wild-type DeaD
-
E168A
-
site-directed mutagenesis, the mutation eliminates ATP hydrolysis and helicase activity, and the mutant is unable to restore PexsD-lacZ activity to levels observed with wild-type DeaD
-
E168Q
-
site-directed mutagenesis, the mutation eliminates ATP hydrolysis and helicase activity, and the mutant is unable to restore PexsD-lacZ activity to levels observed with wild-type DeaD
-
E168A
-
site-directed mutagenesis, the mutation eliminates ATP hydrolysis and helicase activity, and the mutant is unable to restore PexsD-lacZ activity to levels observed with wild-type DeaD
-
E168Q
-
site-directed mutagenesis, the mutation eliminates ATP hydrolysis and helicase activity, and the mutant is unable to restore PexsD-lacZ activity to levels observed with wild-type DeaD
-
E168A
-
site-directed mutagenesis, the mutation eliminates ATP hydrolysis and helicase activity, and the mutant is unable to restore PexsD-lacZ activity to levels observed with wild-type DeaD
-
E168Q
-
site-directed mutagenesis, the mutation eliminates ATP hydrolysis and helicase activity, and the mutant is unable to restore PexsD-lacZ activity to levels observed with wild-type DeaD
-
E909K
site-directed mutagenesis, the temperature-sensitive mutant, encoded by the slt22-1 allele, is synthetically lethal with mutations in U2 or U6 snRNAs that affect the stability or conformation of U2/U6 helix II. The ATPase activity of this variant is no longer stimulated by a U2/ U6 duplex, it is proposed that Brr2 might proofread U2/U6 interactions. The E909K exchange in Brr2 blocks splicing in extracts at or before the first catalytic step and leads to the appearance of an off-pathway spliceosomal particle following B complex formation, which lacks U4 and U5 snRNAs
F162A
kcat/KM for ATP is 1% of wild-type value
F162L
kcat/KM for ATP is 25% of wild-type value
G858R
site-directed mutagenesis, the mutant shows differing cross-linking profiles compared to wild-type Brr2, the mutation is in the NC 5'HP/separator loop with U6 snRNA
K177A
mutant enzyme shows no stimulation of ATPase activity by single-stranded RNA
Q169A
kcat/KM for ATP is 0.3% of wild-type value
Q169E
kcat/KM for ATP is 0.4% of wild-type value
R681C
site-directed mutagenesis, a brr2 mutation linked to the RP33 form of autosomal dominant retinitis pigmentosa, it maps to the linker between the RecA domains of the NC, the mutation leads to altered Brr2 ATPase activity and aberrant partitioning of spliceosomes along activation and discard pathways
R681H
site-directed mutagenesis, a brr2 mutation linked to the RP33 form of autosomal dominant retinitis pigmentosa, it maps to the linker between the RecA domains of the NC, the mutation leads to altered Brr2 ATPase activity and aberrant partitioning of spliceosomes along activation and discard pathways
T166A
kcat/KM for ATP is 37% of wild-type value
T166S
kcat/KM for ATP is 26% of wild-type value
V683L
site-directed mutagenesis, a brr2 mutation linked to the RP33 form of autosomal dominant retinitis pigmentosa, it maps to the linker between the RecA domains of the NC, the mutation leads to altered Brr2 ATPase activity and aberrant partitioning of spliceosomes along activation and discard pathways
Y689C
site-directed mutagenesis, a brr2 mutation linked to the RP33 form of autosomal dominant retinitis pigmentosa, it maps to the beginning of the RecA2 domain
E909K
-
site-directed mutagenesis, the temperature-sensitive mutant, encoded by the slt22-1 allele, is synthetically lethal with mutations in U2 or U6 snRNAs that affect the stability or conformation of U2/U6 helix II. The ATPase activity of this variant is no longer stimulated by a U2/ U6 duplex, it is proposed that Brr2 might proofread U2/U6 interactions. The E909K exchange in Brr2 blocks splicing in extracts at or before the first catalytic step and leads to the appearance of an off-pathway spliceosomal particle following B complex formation, which lacks U4 and U5 snRNAs
-
G858R
-
site-directed mutagenesis, the mutant shows differing cross-linking profiles compared to wild-type Brr2, the mutation is in the NC 5'HP/separator loop with U6 snRNA
-
R681C
-
site-directed mutagenesis, a brr2 mutation linked to the RP33 form of autosomal dominant retinitis pigmentosa, it maps to the linker between the RecA domains of the NC, the mutation leads to altered Brr2 ATPase activity and aberrant partitioning of spliceosomes along activation and discard pathways
-
R681H
-
site-directed mutagenesis, a brr2 mutation linked to the RP33 form of autosomal dominant retinitis pigmentosa, it maps to the linker between the RecA domains of the NC, the mutation leads to altered Brr2 ATPase activity and aberrant partitioning of spliceosomes along activation and discard pathways
-
V683L
-
site-directed mutagenesis, a brr2 mutation linked to the RP33 form of autosomal dominant retinitis pigmentosa, it maps to the linker between the RecA domains of the NC, the mutation leads to altered Brr2 ATPase activity and aberrant partitioning of spliceosomes along activation and discard pathways
-
E300A
-
mutation causes severe defect in RNA unwinding that correlates with reduced rate of ATP hydrolysis
H299A
-
mutation elicits defects in RNA unwinding but spares the ATPase activity
K191A
-
mutation causes severe defect in RNA unwinding that correlates with reduced rate of ATP hydrolysis
R229A
-
mutation causes severe defect in RNA unwinding that correlates with reduced rate of ATP hydrolysis
T192A
-
mutation causes severe defect in RNA unwinding that correlates with reduced rate of ATP hydrolysis
T326A
-
mutation elicits defects in RNA unwinding but spares the ATPase activity
T328A
-
mutation elicits defects in RNA unwinding but spares the ATPase activity
D172A
-
the ration of (kcat/Km)ATP/(kcat/Km)GTP is 41% of the ratio determined for the wild-type enzyme
E169A
-
the ration of (kcat/Km)ATP/(kcat/Km)GTP is 38% of the ratio determined for the wild-type enzyme
E173A
-
the ration of (kcat/Km)ATP/(kcat/Km)GTP is 17% of the ratio determined for the wild-type enzyme
E180A
-
the ration of (kcat/Km)ATP/(kcat/Km)GTP is 35% of the ratio determined for the wild-type enzyme
E182A
-
the ration of (kcat/Km)ATP/(kcat/Km)GTP is 29% of the ratio determined for the wild-type enzyme
F179A
-
the ration of (kcat/Km)ATP/(kcat/Km)GTP is 19% of the ratio determined for the wild-type enzyme
K186A
-
the ration of (kcat/Km)ATP/(kcat/Km)GTP is 15% of the ratio determined for the wild-type enzyme
K187A
-
the ration of (kcat/Km)ATP/(kcat/Km)GTP is 8% of the ratio determined for the wild-type enzyme
Q188A
-
the ration of (kcat/Km)ATP/(kcat/Km)GTP is 33% of the ratio determined for the wild-type enzyme
R170A
-
the ration of (kcat/Km)ATP/(kcat/Km)GTP is 31% of the ratio determined for the wild-type enzyme
R185A
-
inactive mutant enzyme
additional information